Literature DB >> 20164295

Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women.

Tord Naessen1, Ulrika Sjogren, Jonas Bergquist, Marita Larsson, Lars Lind, Mark M Kushnir.   

Abstract

CONTEXT: There is a need for increased knowledge about endogenous sex hormone levels and clinical outcomes of risk/benefit. Immunoassays have poor specificity to reliably measure low steroid concentrations in elderly.
OBJECTIVE: The objective of the study was to evaluate plasma steroid concentrations with regard to prevalent cardiovascular disease (CVD) in elderly, using mass spectrometry.
SETTING: The study was conducted at a university hospital research unit. DESIGN AND METHODS: Plasma samples were analyzed from 202 70-yr-olds as part of a large population-based study, Prospective Investigation of the Vasculature in Uppsala Seniors. Twenty-eight of these had prevalent CVD. Eleven steroids were quantified, using liquid chromatography-tandem mass spectrometry. Women with current/previous menopausal hormone therapy (n = 35) were excluded.
RESULTS: Men without prevalent CVD had higher plasma 17beta-estradiol (E2), compared with women. Men with prevalent CVD, compared with those without, had lower 17-hydroxypregnenolone (17OHPregn), 17-hydroxyprogesterone, and higher estrone/androstenedione and E2/testosterone (T) (aromatase activity). Women with prevalent CVD had lower pregnenolone, 17OHPregn, and dehydroepiandrosterone (DHEA) but higher DHEA/17OHPregn, androstenedione/DHEA, E2/T, E2/estrone, and E2/SHBG. The aromatase index, E2/T, was higher for prevalent CVD in both sexes. Adjustment for statin use, smoking, and body mass index yielded additional significant differences in men, whereas some were lost in women. Logistic regression indicated strong associations between prevalent CVD and low 17OHPregn, adjusted odds ratio of 0.18, 95% confidence interval (0.06-0.61); P = 0.006, in women and low 17-hydroxyprogesterone, 0.45 (0.25-0.80); P = 0.007 in men, most likely caused by increased throughput (consumption) toward estrogen synthesis.
CONCLUSIONS: Prevalent CVD was associated with indications of lower androgen precursors, increased aromatase activity, and higher estrogen levels in both sexes. Results might represent an endogenous response to a condition of developing atherosclerosis, rather than a causative relationship. Furthermore studies are needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164295     DOI: 10.1210/jc.2009-1722

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Immunological and mass spectrometric assays of SHBG: consistent and inconsistent metabolic associations in healthy men.

Authors:  Johannes D Veldhuis; Olga P Bondar; Roy B Dyer; Sergey A Trushin; Eric W Klee; Ravinder J Singh; George G Klee
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  Evidence for geographical and racial variation in serum sex steroid levels in older men.

Authors:  Eric S Orwoll; Carrie M Nielson; Fernand Labrie; Elizabeth Barrett-Connor; Jane A Cauley; Steven R Cummings; Kristine Ensrud; Magnus Karlsson; Edith Lau; P C Leung; Osten Lunggren; Dan Mellström; Alan L Patrick; Marcia L Stefanick; Kozo Nakamura; Noriko Yoshimura; Joseph Zmuda; Liesbeth Vandenput; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2010-07-28       Impact factor: 5.958

3.  Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.

Authors:  Samar R El Khoudary; Nanette Santoro; Hsiang-Yu Chen; Ping G Tepper; Maria M Brooks; Rebecca C Thurston; Imke Janssen; Sioban D Harlow; Emma Barinas-Mitchell; Faith Selzer; Carol A Derby; Elizabeth A Jackson; Daniel McConnell; Karen A Matthews
Journal:  Eur J Prev Cardiol       Date:  2015-09-18       Impact factor: 7.804

4.  Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study.

Authors:  Robin Haring; Zhaoyang Teng; Vanessa Xanthakis; Andrea Coviello; Lisa Sullivan; Shalender Bhasin; Joanne M Murabito; Henri Wallaschofski; Ramachandran S Vasan
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

5.  Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.

Authors:  Margus Viigimaa; Helena Vaverkova; Michel Farnier; Maurizio Averna; Luc Missault; Mary E Hanson; Qian Dong; Arvind Shah; Philippe Brudi
Journal:  Lipids Health Dis       Date:  2010-11-04       Impact factor: 3.876

6.  Circulating Sex Steroids and Vascular Calcification in Community-Dwelling Men: The Framingham Heart Study.

Authors:  Thomas G Travison; Christopher J O'Donnell; Shalender Bhasin; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; Ralph B D'Agostino; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2016-03-01       Impact factor: 5.958

Review 7.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

8.  Sex hormones and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Wesley T O'Neal; Saman Nazarian; Alvaro Alonso; Susan R Heckbert; Viola Vaccarino; Elsayed Z Soliman
Journal:  Endocrine       Date:  2017-08-07       Impact factor: 3.633

9.  Concentrations of nine endogenous steroid hormones in 70-year-old men and women.

Authors:  Johanna Christina Penell; Mark M Kushnir; Lars Lind; Jonatan Bergquist; Jonas Bergquist; P Monica Lind; Tord Naessen
Journal:  Endocr Connect       Date:  2021-05-13       Impact factor: 3.335

10.  Endogenous sex hormones, aromatase activity and lung cancer risk in postmenopausal never-smoking women.

Authors:  Yingya Zhao; Yu-Tang Gao; Xianglan Zhang; Alan L Rockwood; Mark M Kushnir; Qiuyin Cai; Jie Wu; Jiajun Shi; Qing Lan; Nathaniel Rothman; Yu Shyr; Xiao-Ou Shu; Wei Zheng; Gong Yang
Journal:  Int J Cancer       Date:  2022-04-02       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.